Tradestie Institutional Equity Comparison Engine
MLYS vs EWTX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
EWTX Overall Edge
EWTX Captures Institutional Edge (4โ0 Pillars ยท 5โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Edgewise Therapeutics, Inc. Common Stock (EWTX) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, MLYS trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus EWTX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, MLYS sits in BREAKDOWN (39th %ile IV; Dealer Gamma Walls on Pro) against EWTX sits in CONSOLIDATION (17th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
EWTX
MLYS N/M vs EWTX N/M Fwd P/E
Growth & Margin Winner
EWTX
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner
EWTX
1Y -66.6% vs +113.6% ยท 52W Pos 1% vs 82%
Options & Structure Winner
EWTX
BREAKDOWN (39th %ile IV) vs CONSOLIDATION (17th %ile IV)
MLYS
NASDAQ
Mineralys Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$14.79
-3.52% 1D
Market Cap
$1.4B
1M Return
-27.14%
1Y Return
-66.61%
Forward P/E
N/M
Unified AI Score
60.1 / 100
BUY
Tech 73.0
Fund 68.0
Flow 69.0
Mom 60.0
EWTX
NASDAQ
Edgewise Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$43.61
-5.05% 1D
Market Cap
$5.0B
1M Return
+17.26%
1Y Return
+113.57%
Forward P/E
N/M
Unified AI Score
33.6 / 100
SELL
Tech 8.0
Fund 38.0
Flow 66.0
Mom 44.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
MLYS -66.61%
EWTX +113.57%
Spread: +180.18 pp (EWTX Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
MLYS TTM Op. Margin: 0.0%
EWTX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MLYS vs EWTX. Trailing 12-month operating profitability (MLYS 0.0% vs EWTX 0.0%) and valuation multiples (MLYS N/M vs EWTX N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MLYS | EWTX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.4B | $5.0B | Larger Scale | EWTX |
| Trailing P/E Ratio Valuation | N/M | 5.5x | Lower Multiple | EWTX |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | +0.0% | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -68.5% | 92.1% | Higher ROE | EWTX |
| 52-Week Range Position Momentum | 1% ($15โ$47) | 82% ($20โ$49) | Stronger Trend | EWTX |
| Beta / 30D Volatility Risk Regime | 1.70ฮฒ ยท 89% Vol | 1.19ฮฒ ยท 74% Vol | Lower Realized Risk | EWTX |
| Unified Institutional Score Composite Signal | 60.1 / 100 (BUY) | 33.6 / 100 (SELL) | Higher Composite | MLYS |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full MLYS vs EWTX Buy Guide
MLYS
BREAKDOWN
119d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
39th %ile
IV Regime
Balanced (25thโ60th %ile)
EWTX
CONSOLIDATION
91d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
17th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither MLYS nor EWTX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.